You searched for "therapeutics"

276 results found

Cutaneous malignant melanoma metastasis to pseudophakic lens

Metastases to the eye and orbit are rare and intraocular cutaneous malignant melanoma metastasis (ICMM) is exceedingly rare, representing around 5%. There have only been three previous cases of ICMM to the lens in the literature, all of which presented...

Key research and practical information to inform INS care

This ‘tutorial’ format paper aims to translate key research findings and conclusions into practical terms, discuss their clinical utility and introduce a new clinical method that accurately measures the static visual deficits in infantile nystagmus (INS), predicts the improvements that...

SIFI provides regulatory updates for AKANTIOR® (POLIHEXANIDE 0.8 MG/ML) in Europe and the United States

SIFI has announced the accomplishment of several targets concerning the regulatory procedure of polihexanide 0.8 mg/ml for the treatment of acanthamoeba keratitis.

Subthreshold micropulse laser in BRVO

The purpose of this retrospective, consecutive, single-centre, non-randomised, and case-control study was to verify the therapeutic effects and safety of oedema (from branch retinal vein occlusion (BRVO)) recurrence suppression effect using 577-nm subthreshold micropulse laser photocoagulation (SMLP) in combination with...

Type 3 CNV and anti-VEGF

The purpose of the study was to determine the differences between aflibercept and ranibizumab in terms of their therapeutic efficacy in the treatment of Type 3 neovascularisation. The authors highlight that the dominant mechanism for Type 3 neovascularisation development is...

Systemic pharmacology of intravitreal anti-VEGF

This study aimed to evaluate and compare serum drug concentrations and plasma free-VEGF concentrations in patients with AMD, DME, or RVO receiving intravitreal injections of aflibercept, bevacizumab or ranibizumab. This prospective study enrolled patients from several offices of a single...

Anterior segment OCT imaging in cases of episcleritis and scleritis

The purpose of this study was to determine whether it is feasible to obtain good-quality images with anterior segment OCT (AS-OCT) in patients with episcleral or scleral inflammation located anterior to the equator, and whether this technique is able to...

Progression of myopic maculopathy after treatment

The authors report on a retrospective study carried out to evaluate long-term progression of myopic maculopathy and functional outcome in eyes treated for myopic choroidal neovascularisation (CNV) and in eyes without CNV. Fifty-four myopic eyes of 30 patients were included...

Horus Pharma to distribute intravitreal implant ILUVIEN® in France

Intravitreal implant ILUVIEN, developed by Alimera Sciences, is now available in France, distributor Horus Pharma has announced. ILUVIEN is aimed at patients with vision impairment associated with chronic Diabetic Macular Edema (DME), who have not responded well to other available...

Review of non-arteritic anterior ischaemic optic neuropathy

This article reviews the risk factors, clinical presentation and therapies that have been investigated for non-arteritic anterior ischaemic optic neuropathy (NAAION). Additionally, it provides an update from recent rodent and primate models, offering a new insight into the pathophysiology of...

Emerging developments in dry eye

An estimated 344 million people worldwide suffer from dry eye [1]. This chronic syndrome is characterised by a vicious cycle of tear film hyperosmolarity, tear instability and corneal stress, leading to increased friction, inflammation, ocular surface damage and decreased visual...

An eye on novel anti-cancer agents: an evidence-based approach to external eye assessment

Novel anti-cancer therapies have led to significant advancement in cancer treatment, however, they can be associated with external eye complications. It is important to be mindful of such adverse effects during assessment of patients enrolled in clinical trials. Annually, approximately...